Xeljanz Tablet

Product Description

Xeljanz (tofacitinib) belongs to a class of medications called Janus kinase (JAK) inhibitors. It works by decreasing the activity of the immune system.

Xeljanz is used alone or with other medications to treat moderate to severe rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who are unable to take or did not respond to methotrexate or one or more tumor necrosis factor (TNF) inhibitor medication(s).

Xeljanz (tofacitinib) belongs to a class of medications called Janus kinase (JAK) inhibitors. It works by decreasing the activity of the immune system.

Xeljanz is used alone or with other medications to treat moderate to severe rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who are unable to take or did not respond to methotrexate or one or more tumor necrosis factor (TNF) inhibitor medication(s).

Xeljanz is also used to treat psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin) in adults who are unable to take or did not respond to or tolerate one or more TNF inhibitor medication(s).

Xeljanz is used to treat moderate to severe ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) in adults who are unable to take or who did not respond to one or more TNF inhibitor medication(s).

Warning: keep out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed.

The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.